| Literature DB >> 25373875 |
Lena Victoria Nordheim, Marianne Tveit Haavind, Marjolein M Iversen.
Abstract
BACKGROUND: Leg ulcers and diabetes-related foot ulcers are frequent and costly complications of their underlying diseases and thus represent a critical issue for public health. Since the population is aging, the prevalence of these conditions will probably increase considerably and require more resources. Treatment of leg and foot ulcers often demands frequent contact with the health care system, may pose great burden on the patient, and involves follow-up in both primary and specialist care. Telemedicine provides potential for more effective care management of leg and foot ulcers. The objective of this systematic review of the literature was to assess the effect of telemedicine follow-up care on clinical, behavioral or organizational outcomes among patients with leg and foot ulcers.Entities:
Mesh:
Year: 2014 PMID: 25373875 PMCID: PMC4230629 DOI: 10.1186/s12913-014-0565-6
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Search strategy for Ovid MEDLINE
| 1. | Telemedicine/ |
| 2. | Telecommunications/ |
| 3. | Electronic mail/ |
| 4. | Satellite communications/ |
| 5. | Remote consultation/ |
| 6. | Telephone/ |
| 7. | Cellular phone/ |
| 8. | Modems/ |
| 9. | Television/ |
| 10. | Videoconferencing/ |
| 11. | Video recording/ |
| 12. | Webcasts as topic/ |
| 13. | Wireless technology/ |
| 14. | exp Computer communication networks/ |
| 15. | or/1-14 |
| 16. | tele*.tw. |
| 17. | (e-mail* or electronic mail*).tw. |
| 18. | (ehealth* or e-health*).tw. |
| 19. | (e-medicine* or emedicine*).tw. |
| 20. | (videoconferen* or video-conferen*).tw. |
| 21. | (videophone* or video-phone*).tw. |
| 22. | medical record system*.tw. |
| 23. | ((mobile* or phone* or telephone*) adj3 (consult* or counsel*)).tw. |
| 24. | ((mobile* or phone* or telephone*) adj3 (follow up* or support* or interview*)).tw. |
| 25. | (distan* adj4 (health* or consult* or counsel* or monitor*or treatment*)).tw. |
| 26. | (remote* adj4 (health* or consult* or counsel* or monitor* or treatment*)).tw. |
| 27. | image trans*.tw. |
| 28. | picture trans*.tw. |
| 29. | or/16-28 |
| 30. | or/15 or 29 |
| 31. | exp Leg ulcer/ |
| 32. | ((leg or crural or cruris or venous or varicose or stasis or foot or plantar or sole or plantaris or pedis) adj2 (ulc* or sore* or wound*)).tw. |
| 33. | (diabet* adj2 (foot* or feet* or ulc* or sore* or wound*)).tw. |
| 34. | or/31-33 |
| 35. | 30 and 34 |
*The asterisk (*) was used for truncation to search multiple forms of a free-text term (singular/plural, variable spellings, etc.), e.g. “ulc*” to find “ulcer”, “ulcers”, “ulcus”.
Characteristics of excluded studies
|
|
|
|---|---|
| Bowles 2002 [ | Population: Diabetes patients with and without foot ulcers. Separate data for foot ulcers not available. |
| Dobke 2008 [ | Population: Mixed, including patients with pressure ulcers. Separate data for venous/arterial leg ulcers and diabetic foot ulcers not available. |
| Edmondson 2010 [ | Study design: uncontrolled before-after study |
| Edwards 2009 [ | Intervention: not telemedicine follow-up |
| Hands 2006 [ | Population: Mixed, separate data for venous/arterial leg ulcers and diabetic foot ulcers not provided by author. Author confirmed that telemedicine was used for diagnostic purposes rather than follow-up in the majority of patients. |
| Kim 2004 [ | Study design: Prospective cohort study without comparison of exposed (telemedicine follow-up) and non-exposed (no telemedicine follow-up) patients. |
| Lazzarini 2010 [ | Study design: Multiple case study |
| Manuel 2012 [ | Study design: Uncontrolled before-after study |
| Nagykaldi 2003 [ | Study design: Uncontrolled before-after study |
| Population: Diabetes patients. Separate data for ulcers not available. | |
| Nyheim 2010 [ | Study design: Qualitative study |
| Outcomes: Change in knowledge about chronic ulcers among nurses. | |
| Santamaria 2004 [ | Population: Mixed, including pressure ulcers and surgical ulcers. Separate data for foot and leg ulcer patients not available. |
Figure 1Flow chart of study selection process.
Ongoing trials likely to meet inclusions criteria
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Clin. Trials.gov NCT01608425 | Denmark | Randomized study | People with diabetes-related foot ulcers | Telemedicine consultations between ulcer-nurses in the primary sector and the wound clinics at the hospitals in the region. | 2011/2013 |
| Clin. Trials.gov NCT01710774 | Norway | Cluster randomized study (non-inferiority) | People >20 years with diabetes-related foot ulcers enrolled in specialist health care | Telemedicine follow-up care in municipal primary health care in collaboration with specialist health care | 2012/2016 |
| Clin. Trials.gov NCT01814267 | France | Randomized study | People with diabetes-related foot ulcers ≥18 years enrolled in specialist health care | Telemedicine care and follow-up in specialist health care | 2013/2015 |
Characteristics of the included study
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Wilbright, 2004 [ | Non-randomized study | Two local medical centers located 55 miles apart | Total: 140 patients | Real time interactive video consultation, with or without transfer of digital images | Face-to-face follow-up in a specialized diabetes-related foot program | Healing time in days, percentage of ulcer healed after 12 weeks and healing time ratio adjusted for age, ulcer duration (days), location, size, crossover and severity grade | Average healing time in days: Intervention group = 43.2 ± 29.3 |
| (USA) | Intervention group: 20 patients (55% women, average age 55.1 years) | Control group = 45.5 ± 43.4 | |||||
|
| |||||||
| Control group: 120 patients (45% women, average age 56.5 years) | Adjusted ratio for healing time: Intervention group = 1.00 | ||||||
| Control group = 1.40 | |||||||
|
| |||||||
| Percentage of ulcers healed at 12 weeks: Intervention group = 75% | |||||||
| Control group = 81% | |||||||
|
| |||||||
| Not healed or lost to follow-up: Intervention group: 3/20 | |||||||
| Control group: 7/120 | |||||||
| No patient adverse effects were reported. |
Assessment of risk of bias in the included study
|
|
|
|---|---|
| Wilbright et. al. [ | |
|
| No |
|
| No |
|
| No |
|
| Unclear |
|
| No |
|
| No |
|
| Yes |
|
| High risk |
Unclear = the risk of bias is unknown, or not relevant to the study. No = high risk of bias. Yes = low risk of bias.
GRADE assessment of the efficacy of video consultation of patients with leg and foot ulcers
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 [ | Unadjusted healing time (number of days) | Traditional consultation with diabetes-related foot team | 2 | −2 | 0 | 0 | −2 | 0 | Intervention group: 43.5 ± 29.3 | Very low | Degraded because of the study design, high risk of bias and uncertain estimate of effectiveness |
| Control group: 45.5 ± 43.4 | |||||||||||
|
| |||||||||||
| 140 [ | Adjusted healing time | Traditional consultation with diabetes-related foot team | 2 | −2 | 0 | 0 | −2 | 0 | Intervention group: 1.40 | Very low | Degraded because of the study design, high risk of bias and uncertain estimate of effectiveness |
| Control group: 1.00 | |||||||||||
|
| |||||||||||
| 140 [ | Ulcers healed at 12 weeks | Traditional consultation with diabetes-related foot team | 2 | −2 | 0 | 0 | −2 | 0 | Intervention group: 75% | Very low | Degraded because of the study design, high risk of bias and uncertain estimate of effectiveness |
| Control group: 81% | |||||||||||
|
|
Research recommendations for future studies on the effect of telemedicine follow-up care of leg and foot ulcers based on EPICOT format
|
|
| ||
|---|---|---|---|
|
| |||
| E | Evidence | What is the current evidence? | One small study (n = 140) with a non-randomized design conducted in the United States. |
| P | Population | Patients (>20 years) presenting a leg ulcer or diabetes-related foot ulcer to specialist health care. | |
| I | Intervention | Telemedicine follow-up care provided by municipal primary health care in collaboration with specialist health care | |
| C | Comparison | Placebo, routine care, alternative treatment/management | Care as usual. |
| O | Outcome | Which clinical or patient related outcomes will the researcher need to measure, improve, influence or accomplish? Which methods of measurement should be used? | Healing time; total number of consultations per person; sequelae directly related to the foot or leg ulcer: infection, hospitalization, and vascular surgery during the study; patient satisfaction with health care; health status and cost utility; the time elapsing before a new ulcer appears, the incidence of amputation and survival. |
| T | Time stamp | Date of literature search or recommendation | May 16th, 2014. |
|
| |||
| d | Disease burden | Leg ulcers and diabetes-related foot ulcers are longstanding and costly complications of their underlying diseases and represent challenges for individual people and health care system. Treatment of leg ulcers and diabetic foot ulcers often demands frequent contact with the health care system and may pose a great burden on the patient. According to international guidelines patients with leg or foot ulcers should be referred to specialist foot clinics at an early stage. However, in Norway as well as other European countries many foot ulcer patients are treated a substantial time in primary care with lack of expert nurses and doctors and access to specialist health care, which may be problematic as they may not be using the evidence base sufficiently well to support ulcer healing and patient well-being. | |
| t | Timeliness | Time aspects of core elements: | |
| Mean age of the population | 67 years | ||
| Duration of the intervention | 12 months | ||
| Length of follow-up | 3 years | ||
| s | Study type | What is the most appropriate study design to address the proposed question | Cluster- randomized controlled trial |